Articles Archive - Page 50 of 430 - JDDonline - Journal of Drugs in Dermatology

May 16

Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment

By Chuck Lin No Comments

INTRODUCTIONAcne vulgaris is a chronic inflammatory skin disease of the pilosebaceous unit, characterized by permeability barrier dysfunction and reduced ceramide levels in the stratum corneum.1,2 Unfortunately, many acne medications, such…

May 10

Love0

Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa

By Chuck Lin No Comments

INTRODUCTIONHidradenitis suppurativa (HS) is a debilitating chronic inflammatory disease with a single approved treatment, TNF-antagonist adalimumab 40 mg/week (ADA40). However, only half of patients treated with ADA40 achieved Hidradenitis Suppurativa…

May 10

Love0

Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea

By Chuck Lin No Comments

INTRODUCTIONRosacea is a chronic inflammatory skin condition characterized by facial erythema, telangiectasias, and papulopustular lesions, reported in as high as 22% of the population.1,2 Most patients are diagnosed after the…

May 10

Love0

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas

By Chuck Lin No Comments

INTRODUCTIONInfantile hemangiomas (IHs) are a common childhood tumor occurring in 5-10% of children and present as selflimiting vascular endothelial tumors, often involving the head and neck.1 Present at birth followed…

May 09

Love0

Role of Retinoic Acid Receptor Subtypes in the Pathophysiology of Acne

By Chuck Lin No Comments

INTRODUCTIONTopical retinoids are used for a number of dermatological conditions including psoriasis, pigmentary disorders, and skin cancers and are well-established acne treatments.1 These are agonists of retinoic acid receptors (RAR),…

May 05

Love0

Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement

By Chuck Lin No Comments

INTRODUCTIONThe most recent American Academy of Dermatology (AAD) guidelines on acne treatment were published in 2016.1 The Acne Management Consensus Roundtable, a group of dermatologists, was convened in 2022 to…

Apr 28

Love0

Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin

By Chuck Lin No Comments

INTRODUCTIONKeratinocyte carcinomas (KCs), comprising basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), are the most frequently occurring human malignancies. Cure rates are high, but the incidence of KCs is…

Apr 28

Love0

Allergens in Common Brands of Clobetasol

By Chuck Lin No Comments

INTRODUCTIONTopical corticosteroids are one of the most commonly prescribed medications by dermatologists.1 Allergic contact dermatitis (ACD) to topical corticosteroids has been widely recognized since the late 1980s.2 Allergy to corticosteroids…

Apr 28

Love0

Non-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage

By Chuck Lin No Comments

INTRODUCTIONBasal cell carcinoma (BCC) is the most common form of skin cancer in North America.1,2 Although there is a 5-year survival rate of 100% and metastasis is rare (incidence of…

Apr 28

Love0

Diversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship

By Chuck Lin No Comments

INTRODUCTIONThe population of the United States is becoming increasingly diverse. Dermatology lags, particularly amongst Mohs micrographic surgeons, where less than 4.5% identify as underrepresented in medicine (URM).1 It is important…

Apr 27

Love0

Supplement Individual Article: Chelating Agents in Skincare: Comprehensive Protection Against Environmental Aggressors

By Chuck Lin No Comments

INTRODUCTIONAlthough the importance of protecting the skin from sunlight is widely recognized, ultraviolet (UV) light is the main cause of skin damage and premature aging. However, many other outdoor stressors…

Apr 27

Love0

FULL SUPPLEMENT: Environmental Aggressors And Comprehensive Protection: Chelating Agents In Skincare

By Chuck Lin No Comments

In this supplement: Chelating Agents in Skincare: Comprehensive Protection Against Environmental AggressorsIn addition to ultraviolet light, skin is regularly exposed to several environmental stressors that can cause damage and premature…

Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment

Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa

Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas

Role of Retinoic Acid Receptor Subtypes in the Pathophysiology of Acne

Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement

Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin

Allergens in Common Brands of Clobetasol

Non-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage

Diversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship

Supplement Individual Article: Chelating Agents in Skincare: Comprehensive Protection Against Environmental Aggressors

FULL SUPPLEMENT: Environmental Aggressors And Comprehensive Protection: Chelating Agents In Skincare

Search page

Advertisement

Popular

Advertisement

News Topics

News Topics

Journal of Drugs in Dermatology

Search